The Lewy body in Parkinson's disease and related neurodegenerative disorders (Q38012653)

27 August 2017

title

The Lewy body in Parkinson's disease and related neurodegenerative disorders (English)

1 reference

27 August 2017

1 reference

1 reference

Koichi Wakabayashi

1

1 reference

27 August 2017

Kunikazu Tanji

2

1 reference

27 August 2017

Saori Odagiri

3

1 reference

27 August 2017

Yasuo Miki

4

1 reference

27 August 2017

Fumiaki Mori

5

1 reference

27 August 2017

Hitoshi Takahashi

6

1 reference

27 August 2017

publication date

24 May 2012

1 reference

27 August 2017

published in

Molecular Neurobiology

1 reference

27 August 2017

volume

47

1 reference

27 August 2017

issue

2

1 reference

27 August 2017

page(s)

495-508

1 reference

The precursor protein of non-A beta component of Alzheimer's disease amyloid is a presynaptic protein of the central nervous system

27 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1007%2FS12035-012-8280-Y

Mutation in the alpha-synuclein gene identified in families with Parkinson's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-012-8280-Y

Ala30Pro mutation in the gene encoding alpha-synuclein in Parkinson's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-012-8280-Y

The new mutation, E46K, of alpha-synuclein causes Parkinson and Lewy body dementia

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-012-8280-Y

alpha-Synuclein locus triplication causes Parkinson's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-012-8280-Y

Alpha-synuclein in Lewy bodies

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-012-8280-Y

Lewy body in neurodegeneration with brain iron accumulation type 1 is immunoreactive for alpha-synuclein

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-012-8280-Y

Widespread occurrence of alpha-synuclein/NACP-immunoreactive neuronal inclusions in juvenile and adult-onset Hallervorden-Spatz disease with Lewy bodies

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-012-8280-Y

Widespread Lewy body and tau accumulation in childhood and adult onset dystonia-parkinsonism cases with PLA2G6 mutations

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-012-8280-Y

Neuropathology provides clues to the pathophysiology of Gaucher disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-012-8280-Y

Aberrant phosphorylation of alpha-synuclein in human Niemann-Pick type C1 disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-012-8280-Y

Neuronal and glial accumulation of alpha- and beta-synucleins in human lipidoses

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-012-8280-Y

Genetic and pathological links between Parkinson's disease and the lysosomal disorder Sanfilippo syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-012-8280-Y

Alpha-synuclein immunoreactivity in glial cytoplasmic inclusions in multiple system atrophy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-012-8280-Y

Glial cytoplasmic inclusions in white matter oligodendrocytes of multiple system atrophy brains contain insoluble alpha-synuclein.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-012-8280-Y

NACP/alpha-synuclein immunoreactivity in fibrillary components of neuronal and oligodendroglial cytoplasmic inclusions in the pontine nuclei in multiple system atrophy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-012-8280-Y

Immunocytochemical localization of synaptic vesicle-specific protein in lewy body-containing neurons in Parkinson's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-012-8280-Y

Lewy bodies in cerebral cortex, report of three cases

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-012-8280-Y

Ubiquitin is a common factor in intermediate filament inclusion bodies of diverse type in man, including those of Parkinson's disease, Pick's disease, and Alzheimer's disease, as well as Rosenthal fibres in cerebellar astrocytomas, cytoplasmic bodie

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-012-8280-Y

Lewy bodies are ubiquitinated. A light and electron microscopic immunocytochemical study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-012-8280-Y

Accumulation of phosphorylated alpha-synuclein in aging human brain

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-012-8280-Y

Hippocampal degeneration differentiates diffuse Lewy body disease (DLBD) from Alzheimer's disease: Light and electron microscopic immunocytochemistry of CA2-3 neurites specific to DLBD

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-012-8280-Y

Argyrophilic glial inclusions in the midbrain of patients with Parkinson's disease and diffuse Lewy body disease are immunopositive for NACP/alpha-synuclein

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-012-8280-Y

Widespread occurrence of argyrophilic glial inclusions in Parkinson's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-012-8280-Y

Incidence and extent of Lewy body-related alpha-synucleinopathy in aging human olfactory bulb

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-012-8280-Y

The hypothalamus in parkinson disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-012-8280-Y

The distribution of Lewy bodies in the central and autonomic nervous systems in idiopathic paralysis agitans

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-012-8280-Y

Parkinson's disease: Distribution of Lewy bodies and monoamine neuron system

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-012-8280-Y

Alpha-synuclein accumulates in Purkinje cells in Lewy body disease but not in multiple system atrophy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-012-8280-Y

Lewy bodies in the lower sacral parasympathetic neurons of a patient with Parkinson's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-012-8280-Y

The intermediolateral nucleus and Clarke's column in Parkinson's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-012-8280-Y

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-012-8280-Y

Amygdala pathology in Parkinson's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-012-8280-Y

Cortical Lewy body-containing neurons are pyramidal cells: laser confocal imaging of double-immunolabeled sections with anti-ubiquitin and SMI32.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-012-8280-Y

Ultrastructure of Lewy bodies in the stellate ganglion

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-012-8280-Y

Gastric alpha-synuclein immunoreactive inclusions in Meissner's and Auerbach's plexuses in cases staged for Parkinson's disease-related brain pathology

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-012-8280-Y

Colonic biopsies to assess the neuropathology of Parkinson's disease and its relationship with symptoms

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-012-8280-Y

Multi-organ distribution of phosphorylated alpha-synuclein histopathology in subjects with Lewy body disorders

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-012-8280-Y

Axonal alpha-synuclein aggregates herald centripetal degeneration of cardiac sympathetic nerve in Parkinson's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-012-8280-Y

Neuropathology of autonomic nervous system in Parkinson's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-012-8280-Y

Do alpha-synuclein aggregates in autonomic plexuses predate Lewy body disorders?: a cohort study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-012-8280-Y

Lewy pathology in the submandibular gland of individuals with incidental Lewy body disease and sporadic Parkinson's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-012-8280-Y

Lewy body pathology involves cutaneous nerves

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-012-8280-Y

Clinical availability of skin biopsy in the diagnosis of Parkinson's disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-012-8280-Y

Involvement of the peripheral nervous system in synucleinopathies, tauopathies and other neurodegenerative proteinopathies of the brain

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-012-8280-Y

The Parkinson's complex: parkinsonism is just the tip of the iceberg

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-012-8280-Y

Overview of the extranigral aspects of Parkinson disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-012-8280-Y

Association of olfactory dysfunction with incidental Lewy bodies

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-012-8280-Y

Bowel movement frequency in late-life and incidental Lewy bodies

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-012-8280-Y

Reduced striatal tyrosine hydroxylase in incidental Lewy body disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-012-8280-Y

Incidental Lewy body disease and preclinical Parkinson disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-012-8280-Y

Evidence that incidental Lewy body disease is pre-symptomatic Parkinson's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-012-8280-Y

Incidental Lewy body disease: electrophysiological findings suggesting pre-clinical Lewy body disorders

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-012-8280-Y

Staging of brain pathology related to sporadic Parkinson's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-012-8280-Y

Stanley Fahn Lecture 2005: The staging procedure for the inclusion body pathology associated with sporadic Parkinson's disease reconsidered

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-012-8280-Y

Diagnosis and management of dementia with Lewy bodies: third report of the DLB Consortium

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-012-8280-Y

The dorsal motor nucleus of the vagus is not an obligatory trigger site of Parkinson's disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-012-8280-Y

Applicability of current staging/categorization of alpha-synuclein pathology and their clinical relevance

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-012-8280-Y

Evidence in favor of Braak staging of Parkinson's disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-012-8280-Y

A critical reappraisal of current staging of Lewy-related pathology in human brain

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-012-8280-Y

The dorsal motor nucleus of the vagus is not an obligatory trigger site of Parkinson's disease: a critical analysis of alpha-synuclein staging

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-012-8280-Y

Empiric refinement of the pathologic assessment of Lewy-related pathology in the dementia patient

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-012-8280-Y

Patterns and stages of alpha-synucleinopathy: Relevance in a population-based cohort.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-012-8280-Y

Unified staging system for Lewy body disorders: correlation with nigrostriatal degeneration, cognitive impairment and motor dysfunction

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-012-8280-Y

Olfactory bulb alpha-synucleinopathy has high specificity and sensitivity for Lewy body disorders

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-012-8280-Y

Colloid (hyaline) inclusion bodies in the central nervous system: their presence in the substantia nigra is diagnostic of Parkinson's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-012-8280-Y

Relationships between Lewy bodies and pale bodies in Parkinson's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-012-8280-Y

Accumulation of alpha-synuclein/NACP is a cytopathological feature common to Lewy body disease and multiple system atrophy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-012-8280-Y

Morphogenesis of Lewy bodies: dissimilar incorporation of alpha-synuclein, ubiquitin, and p62.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-012-8280-Y

An antibody with high reactivity for disease-associated α-synuclein reveals extensive brain pathology

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-012-8280-Y

Developmental stages of cortical Lewy bodies and their relation to axonal transport blockage in brains of patients with dementia with Lewy bodies

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-012-8280-Y

Pale neurites, premature α-synuclein aggregates with centripetal extension from axon collaterals.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-012-8280-Y

Relationship among alpha-synuclein accumulation, dopamine synthesis, and neurodegeneration in Parkinson disease substantia nigra

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-012-8280-Y

The Lewy body in Parkinson's disease: molecules implicated in the formation and degradation of alpha-synuclein aggregates

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-012-8280-Y

Lewy Bodies of Parkinson's Disease Contain Neurofilament Antigens

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-012-8280-Y

Agrin binds alpha-synuclein and modulates alpha-synuclein fibrillation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-012-8280-Y

14-3-3 proteins in Lewy bodies in Parkinson disease and diffuse Lewy body disease brains

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-012-8280-Y

14-3-3 protein is a component of Lewy bodies in Parkinson's disease-mutation analysis and association studies of 14-3-3 eta.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-012-8280-Y

Microtubule-associated protein 1B is a component of cortical Lewy bodies and binds alpha-synuclein filaments

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-012-8280-Y

Immunocytochemical localization of synphilin-1, an alpha-synuclein-associated protein, in neurodegenerative disorders

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-012-8280-Y

Synphilin-1 and parkin show overlapping expression patterns in human brain and form aggresomes in response to proteasomal inhibition

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-012-8280-Y

The presence of tau distinguishes Lewy bodies of diffuse Lewy body disease from those of idiopathic Parkinson disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-012-8280-Y

Colocalization of Tau and Alpha-Synuclein Epitopes in Lewy Bodies

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-012-8280-Y

Dorfin localizes to the ubiquitylated inclusions in Parkinson's disease, dementia with Lewy bodies, multiple system atrophy, and amyotrophic lateral sclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-012-8280-Y

Dorfin Localizes to Lewy Bodies and Ubiquitylates Synphilin-1

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-012-8280-Y

Glycogen synthase kinase-3beta is associated with Parkinson's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-012-8280-Y

NUB1 suppresses the formation of Lewy body-like inclusions by proteasomal degradation of synphilin-1

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-012-8280-Y

Immunohistochemical localization of NUB1, a synphilin-1-binding protein, in neurodegenerative disorders

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-012-8280-Y

Parkin localizes to the Lewy bodies of Parkinson disease and dementia with Lewy bodies

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-012-8280-Y

Pael-R is accumulated in Lewy bodies of Parkinson's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-012-8280-Y

Prolyl-isomerase Pin1 accumulates in lewy bodies of parkinson disease and facilitates formation of alpha-synuclein inclusions

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-012-8280-Y

Ubiquitylation of synphilin-1 and alpha-synuclein by SIAH and its presence in cellular inclusions and Lewy bodies imply a role in Parkinson's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-012-8280-Y

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-012-8280-Y

TRAF6 promotes atypical ubiquitination of mutant DJ-1 and alpha-synuclein and is localized to Lewy bodies in sporadic Parkinson's disease brains.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-012-8280-Y

TRIM9, a novel brain-specific E3 ubiquitin ligase, is repressed in the brain of Parkinson's disease and dementia with Lewy bodies

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-012-8280-Y

Pathological lesions of Alzheimer's disease and dementia with Lewy bodies brains exhibit immunoreactivity to an ATPase that is a regulatory subunit of the 26S proteasome

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-012-8280-Y

Proteasomal inhibition by alpha-synuclein filaments and oligomers.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-012-8280-Y

Phosphorylated IkappaBalpha is a component of Lewy body of Parkinson's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-012-8280-Y

Multicatalytic proteinase is present in Lewy bodies and neurofibrillary tangles in diffuse Lewy body disease brains

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-012-8280-Y

Multicatalytic proteinase is associated with characteristic oval structures in cortical Lewy bodies: an immunocytochemical study with light and electron microscopy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-012-8280-Y

NEDD8 protein is involved in ubiquitinated inclusion bodies

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-012-8280-Y

The p38 subunit of the aminoacyl-tRNA synthetase complex is a Parkin substrate: linking protein biosynthesis and neurodegeneration.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-012-8280-Y

Ubiquitin carboxyl-terminal hydrolase (PGP 9.5) is selectively present in ubiquitinated inclusion bodies characteristic of human neurodegenerative diseases

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-012-8280-Y

Selective molecular alterations in the autophagy pathway in patients with Lewy body disease and in models of alpha-synucleinopathy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-012-8280-Y

Localization of MAP1-LC3 in vulnerable neurons and Lewy bodies in brains of patients with dementia with Lewy bodies

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-012-8280-Y

Alteration of autophagosomal proteins (LC3, GABARAP and GATE-16) in Lewy body disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-012-8280-Y

Glucocerebrosidase is present in α-synuclein inclusions in Lewy body disorders

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-012-8280-Y

Autophagic adapter protein NBR1 is localized in Lewy bodies and glial cytoplasmic inclusions and is involved in aggregate formation in α-synucleinopathy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-012-8280-Y

The deacetylase HDAC6 regulates aggresome formation and cell viability in response to misfolded protein stress

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-012-8280-Y

The co-chaperone carboxyl terminus of Hsp70-interacting protein (CHIP) mediates alpha-synuclein degradation decisions between proteasomal and lysosomal pathways

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-012-8280-Y

Expression of survivin, an inhibitor of apoptosis protein, in tumors of the nervous system

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-012-8280-Y

DnaJB6 is present in the core of Lewy bodies and is highly up-regulated in parkinsonian astrocytes.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-012-8280-Y

Chaperone suppression of alpha-synuclein toxicity in a Drosophila model for Parkinson's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-012-8280-Y

TorsinA and heat shock proteins act as molecular chaperones: suppression of alpha-synuclein aggregation

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-012-8280-Y

A close association of torsinA and alpha-synuclein in Lewy bodies: a fluorescence resonance energy transfer study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-012-8280-Y

Immunohistochemistry using antibodies to alpha-interferon and its induced protein, MxA, in Alzheimer's and Parkinson's disease brain tissues.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-012-8280-Y

Glycoxidation and oxidative stress in Parkinson disease and diffuse Lewy body disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-012-8280-Y

Crosslinking of alpha-synuclein by advanced glycation endproducts--an early pathophysiological step in Lewy body formation?

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-012-8280-Y

The expression of DJ-1 (PARK7) in normal human CNS and idiopathic Parkinson's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-012-8280-Y

Quantitative proteomic analysis of mitochondrial proteins: relevance to Lewy body formation and Parkinson's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-012-8280-Y

Ectopic localization of FOXO3a protein in Lewy bodies in Lewy body dementia and Parkinson's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-012-8280-Y

Cellular glutathione peroxidase in human brain: cellular distribution, and its potential role in the degradation of Lewy bodies in Parkinson's disease and dementia with Lewy bodies

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-012-8280-Y

Neural heme oxygenase-1 expression in idiopathic Parkinson's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-012-8280-Y

Dementia with beta-amyloid deposition: involvement of alpha B-crystallin supports two main diseases

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-012-8280-Y

alpha B crystallin expression in non-lenticular tissues and selective presence in ubiquitinated inclusion bodies in human disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-012-8280-Y

Ca2+/calmodulin-dependent protein kinase II immunoreactivity in Lewy bodies

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-012-8280-Y

Active, phosphorylation-dependent mitogen-activated protein kinase (MAPK/ERK), stress-activated protein kinase/c-Jun N-terminal kinase (SAPK/JNK), and p38 kinase expression in Parkinson's disease and Dementia with Lewy bodies.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-012-8280-Y

The role of G-protein-coupled receptor kinase 5 in pathogenesis of sporadic Parkinson's disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-012-8280-Y

Kinase activity is required for the toxic effects of mutant LRRK2/dardarin

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-012-8280-Y

LRRK2 expression in normal and pathologic human brain and in human cell lines

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-012-8280-Y

LRRK2 protein is a component of lewy bodies

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-012-8280-Y

LRRK2 in Parkinson's disease and dementia with Lewy bodies

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-012-8280-Y

PINK1 protein in normal human brain and Parkinson's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-012-8280-Y

Glial involvement in the degeneration process of Lewy body-bearing neurons and the degradation process of Lewy bodies in brains of dementia with Lewy bodies

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-012-8280-Y

p35nck5a and cyclin-dependent kinase 5 colocalize in Lewy bodies of brains with Parkinson's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-012-8280-Y

Tissue transglutaminase-induced aggregation of alpha-synuclein: Implications for Lewy body formation in Parkinson's disease and dementia with Lewy bodies

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-012-8280-Y

Abnormal patterns of microtubule-associated protein-2 (MAP-2) immunolabeling in neuronal nuclei and Lewy bodies in Parkinson's disease substantia nigra brain tissues

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-012-8280-Y

Association of the cytoskeletal GTP-binding protein Sept4/H5 with cytoplasmic inclusions found in Parkinson's disease and other synucleinopathies

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-012-8280-Y

Natively unfolded tubulin polymerization promoting protein TPPP/p25 is a common marker of alpha-synucleinopathies

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-012-8280-Y

p25alpha Stimulates alpha-synuclein aggregation and is co-localized with aggregated alpha-synuclein in alpha-synucleinopathies

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-012-8280-Y

Depletion of 26S proteasomes in mouse brain neurons causes neurodegeneration and Lewy-like inclusions resembling human pale bodies.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-012-8280-Y

Role of cytochrome c as a stimulator of alpha-synuclein aggregation in Lewy body disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-012-8280-Y

Loss of function mutations in the gene encoding Omi/HtrA2 in Parkinson's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-012-8280-Y

Accumulation of HtrA2/Omi in neuronal and glial inclusions in brains with alpha-synucleinopathies

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-012-8280-Y

Cell cycle aberrations by alpha-synuclein over-expression and cyclin B immunoreactivity in Lewy bodies.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-012-8280-Y

Expression patterns of retinoblastoma protein in Parkinson disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-012-8280-Y

Lewy bodies contain beta-amyloid precursor proteins of Alzheimer's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-012-8280-Y

Relative sparing in Parkinson's disease of substantia nigra dopamine neurons containing calbindin-D28K.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-012-8280-Y

Cell type specific sequestration of choline acetyltransferase and tyrosine hydroxylase within Lewy bodies

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-012-8280-Y

Synaptophysin and chromogranin A immunoreactivities of Lewy bodies in Parkinson's disease brains

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-012-8280-Y

The autosomal recessive juvenile Parkinson disease gene product, parkin, interacts with and ubiquitinates synaptotagmin XI

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-012-8280-Y

Tyrosine hydroxylase protein in Lewy bodies of parkinsonian and senile brains

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-012-8280-Y

Positive immunoreactivity for vesicular monoamine transporter 2 in Lewy bodies and Lewy neurites in substantia nigra

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-012-8280-Y

Basic fibroblast growth factor binds to filamentous inclusions of neurodegenerative diseases

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-012-8280-Y

Complement activation in the Parkinson's disease substantia nigra: an immunocytochemical study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-012-8280-Y

Interaction of TPPP/p25 protein with glyceraldehyde-3-phosphate dehydrogenase and their co-localization in Lewy bodies

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-012-8280-Y

A possible role for humoral immunity in the pathogenesis of Parkinson's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-012-8280-Y

Sphingomyelin in Lewy inclusion bodies in Parkinson's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-012-8280-Y

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-012-8280-Y

Tropomyosin distinguishes Lewy bodies of Parkinson disease from other neurofibrillary pathology

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-012-8280-Y

Proteomic identification of novel proteins in cortical lewy bodies

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-012-8280-Y

Basal forebrain neurons in the dementia of Parkinson disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-012-8280-Y

Apolipoprotein E epsilon4 allele and progression of cortical Lewy body pathology in Parkinson's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-012-8280-Y

Cortical Lewy bodies and Alzheimer-type changes in patients with Parkinson's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-012-8280-Y

Alpha-synuclein, especially the Parkinson's disease-associated mutants, forms pore-like annular and tubular protofibrils

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-012-8280-Y

Annular alpha-synuclein protofibrils are produced when spherical protofibrils are incubated in solution or bound to brain-derived membranes

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-012-8280-Y

Neurodegenerative disease: amyloid pores from pathogenic mutations

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-012-8280-Y

Alpha-synuclein phosphorylation controls neurotoxicity and inclusion formation in a Drosophila model of Parkinson disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-012-8280-Y

Proteasome mediates dopaminergic neuronal degeneration, and its inhibition causes alpha-synuclein inclusions

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-012-8280-Y

Lewy-body formation is an aggresome-related process: a hypothesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-012-8280-Y

Aggresomes formed by alpha-synuclein and synphilin-1 are cytoprotective

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-012-8280-Y

The role of autophagy-lysosome pathway in neurodegeneration associated with Parkinson's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-012-8280-Y

HDAC6 rescues neurodegeneration and provides an essential link between autophagy and the UPS

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-012-8280-Y

Selective autophagy mediated by autophagic adapter proteins

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-012-8280-Y

Does alpha-synuclein modulate dopaminergic synaptic content and tone at the synapse?

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-012-8280-Y

C-terminal alpha-synuclein immunoreactivity in structures other than Lewy bodies in neurodegenerative disorders

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-012-8280-Y

Proteinase K-resistant alpha-synuclein is deposited in presynapses in human Lewy body disease and A53T alpha-synuclein transgenic mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-012-8280-Y

Synphilin-1-binding protein NUB1 is colocalized with nonfibrillar, proteinase K-resistant α-synuclein in presynapses in Lewy body disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-012-8280-Y

Lewy body densities in the entorhinal and anterior cingulate cortex predict cognitive deficits in Parkinson's disease

21 January 2018

1 reference

12 December 2020

TorsinA accumulation in Lewy bodies in sporadic Parkinson's disease

1 reference

12 December 2020

Gallyas-positive, tau-negative glial inclusions in Parkinson's disease midbrain

1 reference

12 December 2020

Neuronal inclusions of Parkinson's disease

1 reference

12 December 2020

Pathology associated with sporadic Parkinson's disease--where does it end?

1 reference

12 December 2020

Clusterin/apolipoprotein J is associated with cortical Lewy bodies: immunohistochemical study in cases with alpha-synucleinopathies

1 reference

12 December 2020

Cyclin-dependent kinase 5 (Cdk5) associated with Lewy bodies in diffuse Lewy body disease

1 reference

12 December 2020

Parkinson's disease: lesions in dorsal horn layer I, involvement of parasympathetic and sympathetic pre- and postganglionic neurons

1 reference

12 December 2020

Cu/Zn superoxide dismutase-like immunoreactivity is present in Lewy bodies from Parkinson disease: a light and electron microscopic immunocytochemical study

1 reference

12 December 2020

Cortical and brainstem-type Lewy bodies are immunoreactive for the cyclin-dependent kinase 5

1 reference

12 December 2020

Abnormal accumulation of phospholipase C-delta in filamentous inclusions of human neurodegenerative diseases

1 reference

12 December 2020

Synphilin-1 is present in Lewy bodies in Parkinson's disease

1 reference

12 December 2020

Parkinson's disease: the presence of Lewy bodies in Auerbach's and Meissner's plexuses

1 reference

12 December 2020

Localization of CKII beta subunits in Lewy bodies of Parkinson's disease

1 reference

12 December 2020

Caspase-cleaved transactivation response DNA-binding protein 43 in Parkinson's disease and dementia with Lewy bodies

1 reference

12 December 2020

Clinicopathological outline of dementia with Lewy bodies applying the revised criteria: the Hisayama study

1 reference

12 December 2020

Accumulation of histone deacetylase 6, an aggresome-related protein, is specific to Lewy bodies and glial cytoplasmic inclusions

1 reference

12 December 2020

Do neuronal inclusions kill the cell?

1 reference

12 December 2020

First appraisal of brain pathology owing to A30P mutant alpha-synuclein

1 reference

12 December 2020

Aggregation of alpha-synuclein in Lewy bodies of sporadic Parkinson's disease and dementia with Lewy bodies.

1 reference

12 December 2020

alpha-Synuclein pathology in the neostriatum in Parkinson's disease

1 reference

12 December 2020

In situ and in vitro study of colocalization and segregation of alpha-synuclein, ubiquitin, and lipids in Lewy bodies

1 reference

12 December 2020

Lewy bodies contain epitopes both shared and distinct from Alzheimer neurofibrillary tangles.

1 reference

12 December 2020

Abnormal accumulation of NACP/alpha-synuclein in neurodegenerative disorders

1 reference

12 December 2020

Phosphorylated α-synuclein immunoreactivity in the posterior pituitary lobe

1 reference

12 December 2020

Aggregation of alpha-synuclein/NACP in the neuronal and glial cells in diffuse Lewy body disease: a survey of six patients.

1 reference

12 December 2020

Epitope map of neurofilament protein domains in cortical and peripheral nervous system Lewy bodies

1 reference

12 December 2020

Analysis of the adrenal gland is useful for evaluating pathology of the peripheral autonomic nervous system in lewy body disease

1 reference

12 December 2020

Parkinson's disease: affection of brain stem nuclei controlling premotor and motor neurons of the somatomotor system

1 reference

12 December 2020

Alpha-synuclein pathology affecting Bergmann glia of the cerebellum in patients with alpha-synucleinopathies

1 reference

12 December 2020

NACP/alpha-synuclein-positive filamentous inclusions in astrocytes and oligodendrocytes of Parkinson's disease brains

1 reference

12 December 2020

Immunohistochemistry of neuronal inclusions in the cerebral cortex and brain-stem in Lewy body disease

1 reference

12 December 2020

Histone deacetylase (HDAC) 4 involvement in both Lewy and Marinesco bodies

1 reference

12 December 2020

Lewy body-type degeneration in cardiac plexus in Parkinson's and incidental Lewy body diseases

1 reference

12 December 2020

alpha-Synuclein is phosphorylated in synucleinopathy lesions

1 reference

12 December 2020

Lewy bodies in Alzheimer's disease: a neuropathological review of 145 cases using alpha-synuclein immunohistochemistry.

1 reference

12 December 2020

Lewy bodies in the cerebellar dentate nucleus of a patient with Parkinson's disease

1 reference

12 December 2020

Lewy bodies in Parkinson's disease are recognized by antibodies to complement proteins

1 reference

12 December 2020

Microtubule-associated protein 5 is a component of Lewy bodies and Lewy neurites in the brainstem and forebrain regions affected in Parkinson's disease

1 reference

12 December 2020

Chondroitin sulfate proteoglycans are a common component of neuronal inclusions and astrocytic reaction in neurodegenerative diseases

1 reference

12 December 2020

Accumulation of NEDD8 in neuronal and glial inclusions of neurodegenerative disorders

1 reference

12 December 2020

Lewy bodies are immunoreactive with antibodies raised to gelsolin related amyloid-Finnish type

1 reference

12 December 2020

Immunocytochemical co-localization of the proteasome in ubiquitinated structures in neurodegenerative diseases and the elderly.

1 reference

12 December 2020

10.1007/S12035-012-8280-Y

Identifiers

DOI

1 reference

Dimensions Publication ID

27 August 2017

1012852750

0 references

1 reference